For over a decade, the influential National Comprehensive Cancer Network (NCCN) has been recommending that men with low-risk prostate cancer be offered active surveillance as the lone “preferred”
A potential new urine biomarker for prostate cancer not only spots the presence of aggressive tumors, it also indicates the amount of these tumors, according to a recent
CHICAGO ― The long-term side effects of hypofractionated postoperative prostate bed radiotherapy (HYPORT) for prostate cancer are similar to those of conventional radiotherapy, a new study concludes. “Hypofractionation
The risk of developing psoriatic arthritis (PsA) may increase as the severity of psoriasis increases, results from a large analysis of U.S. medical records demonstrated. Factors that predict
There will be “routine application” and “broader acceptance” of minimally invasive focal therapies for early-stage prostate cancer within the next 5 years in the United States, predict a
NEW YORK (Reuters Health) – Undergoing prostate biopsy appears to lead to a brief reduction in erectile function which may resolve within months, although data are scarce and
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
